Comparison of the Adverse Event Profile of TheraSphere® with SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma: A Systematic Review
Crossref DOI link: https://doi.org/10.1007/s00270-017-1594-4
Published Online: 2017-02-28
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kallini, Joseph Ralph
Gabr, Ahmed
Thorlund, Kristian
Balijepalli, Chakrapani
Ayres, Dieter
Kanters, Steve
Ebrahim, Shanil
Mills, Edward
Lewandowski, Robert J.
Salem, Riad
Funding for this research was provided by:
BTG International Inc.
License valid from 2017-02-28